Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Xinda Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Tianjin, China, and operates as a key subsidiary of the Tianjin Pharmaceutical Group. Established in 1994, the company focuses on the development, production, and commercialization of finished dosage forms, particularly in the anti-infective, cardiovascular, and respiratory therapeutic areas. Its product portfolio includes widely used generic medications such as Cefaclor, Azithromycin, and Amlodipine. The company maintains advanced manufacturing facilities that are fully compliant with national GMP standards, supporting its role as a significant supplier in the Chinese domestic healthcare market and various international regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Development Xinda Chemical.